Patients with type 2 diabetes who are also taking insulin or sulfonylureas should be monitored closely for hypoglycemia risk when discontinuing Zepbound or switching to alternative medications
The impending patent cliff for semaglutide in India and other countries has become a keenly watched opportunity for various players, as it is expected to unlock a new therapy market for drugmakers, which is projected to unlock a $100 billion market opportunity by the end of this decade
Specifically, the former cohort's BrAC levels rose much more slowly than in the control group, with observed between-group differences being most pronounced in the first 20 minutes
Long-term deficiency can damage the protective myelin around nerves, and if it is not addressed, some of that damage can become permanent, causing numbness, pain, and balance problems
However, they can be significant enough to cause discontinuation in some individuals